Midazolam In Sodium Chloride Injection, Solution
Product Images NDC 68083-619

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Midazolam In Sodium Chloride (NDC 68083-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Midazolam-carton-label-100mg (Midazolam Carton Label 100mg)

Midazolam-carton-label-100mg (Midazolam Carton Label 100mg)
Packaging label for Midazolam in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL) solution for intravenous use. The label indicates it is a single-dose container with 10 single-dose bags per package. Manufactured by Gland Pharma Limited in Hyderabad, India.*
FDA Label Image

Midazolam-carton-label-50mg (Midazolam Carton Label 50mg)

Midazolam-carton-label-50mg (Midazolam Carton Label 50mg)
Packaging label for Midazolam in 0.9% Sodium Chloride Injection, 50 mg per 50 mL (1 mg/mL) in solution for intravenous use. The label states 'For Intravenous Use Only' and 'Do Not Dilute.' It specifies 10 single-dose bags per package. Manufactured by Gland Pharma Limited, Hyderabad, India, with NDC 68083-618-10.*
FDA Label Image

Midazolam-pouch-label-100mg (Midazolam Pouch Label 100mg)

Midazolam-pouch-label-100mg (Midazolam Pouch Label 100mg)
Label for Midazolam in 0.9% Sodium Chloride Injection, 1 mg/mL (100 mg per 100 mL) solution for intravenous use. The single-dose vial is marked as a high alert medication and cautions against dilution, supplementary medication, or series connections. Manufactured by Gland Pharma Limited, Hyderabad, India. Storage conditions and handling instructions are also provided on the label.*
FDA Label Image

Midazolam-pouch-label-50mg (Midazolam Pouch Label 50mg)

Midazolam-pouch-label-50mg (Midazolam Pouch Label 50mg)
Label for Midazolam in 0.9% Sodium Chloride Injection, 1 mg/mL (50 mg per 50 mL) intravenous solution. The single-dose container is labeled as a high alert medication with instructions not to dilute or add supplementary medication. Manufactured by Gland Pharma Limited, Hyderabad, India, the label includes storage conditions, warnings, and a barcode.*
FDA Label Image

Midazolam-spl-infusion-bag-label-100mg (Midazolam Spl Infusion Bag Label 100mg)

Midazolam-spl-infusion-bag-label-100mg (Midazolam Spl Infusion Bag Label 100mg)
Label for Midazolam in 0.9% Sodium Chloride Injection, 1 mg/mL (100 mg per 100 mL) intravenous injection solution. The label indicates it is a high alert medication for intravenous use only and is supplied in a single-dose 100 mL container. Manufactured by Gland Pharma Limited, India. Includes storage instructions and a barcode.*
FDA Label Image

Midazolam-infusion-bag-label-50mg (Midazolam Spl Infusion Bag Label 50mg)

Midazolam-infusion-bag-label-50mg (Midazolam Spl Infusion Bag Label 50mg)
Label for Midazolam in 0.9% Sodium Chloride Injection, 50 mg per 50 mL (1 mg/mL) solution for intravenous use. The label states it is a high alert medication, single-dose container, and manufactured by Gland Pharma Limited. The label includes storage instructions, a barcode, and cautions against dilution and supplementary medication.*
FDA Label Image

Midazolam-structure (Midazolam Structure)

Midazolam-structure (Midazolam Structure)
Chemical structure of the active ingredient Midazolam, showing the molecular arrangement including aromatic rings, nitrogen atoms, and halogen substitutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.